This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Monday's Asia ADR Recap

Indian stocks dropped for the third day in a row Monday, after news broke that federal prosecutors are probing the nation's largest drugmaker Ranbaxy Laboratories for allegedly misleading the U.S. government about the quality of its low-cost drugs when seeking approval for its products in the U.S. Selling in the Indian IT sector also pressured the Sensex lower after Morgan Stanley warned Far East investors that further failures of U.S.-based financial companies could hit the sector hard.

Stocks from India making moves and news in the U.S. include Infosys Technologies (INFY), ICICI Bank (IBN) and Sterlite Industries India (SLT).

Chinese stocks traded mixed on Monday with shares in mainland China rising and shares in Hong Kong trading lower, as Far East investors squared up positions and remained on the sidelines ahead of major economic data due out later this week. Traders said that the market will be focused on June inflation data that is set to be released on Thursday.

Stocks from China making moves and news in the U.S. include Baidu.com (BIDU), Shanda Interactive Entertainment (SNDA), Canadian Solar (CSIQ) and Qiao Xing Universal Telephone (XING).

For the rest of the article, including detailed analysis of the latest activity surrounding these and other Chinese and Indian stocks, please click here.

Be sure, also, to check out the Far East Portfolio at Stockpickr.com every night.

Stockpickr is a wholly owned subsidiary of TheStreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,583.76 +184.09 1.12%
S&P 500 1,935.14 +31.13 1.64%
NASDAQ 4,401.9640 +85.89 1.99%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs